Kraig Biocraft Laboratories Inc (Public, PINK:KBLB)

77 Kommentare / 0 neu
24.04.2011 20:26
#1
Bild des Benutzers b00n
Offline
Kommentare: 5227
Kraig Biocraft Laboratories Inc (Public, PINK:KBLB)

http://www.kraiglabs.com/

hat langsan nen eigenen thread verdient..

nach den lang ersehnten partnering news

Sigma-Aldrich and Kraig Biocraft Laboratories Successfully Negotiate License Agreement

Sigma-Aldrich and Kraig to Work Together to Create the Next Generation Biomaterials

Sigma-Aldrich Becomes Kraig Shareholder

These are the types of deals we love to see, a billion dollar well known drug company investing real money and time in a small micro cap company. It does not get any better than this. The 52 week trading range of (KBLB) is .01 – .26 cents.

Kraig Biocraft Laboratories has major support at .10 with volume with buying pressure. (KBLB.PK) stock closed up just under 11% and has traded as high as .26 cents without having this deal in place with Sigma-Aldrich. Now that Sigma-Aldrich and Kraig Biocraft Labortories are working together we feel the stock could very well break the 52 week high of .26 cents and head way past that. When SIgma-Aldrich and Kraig Biocraft put this product into production is will revolutionize the textile industry and create massive amounts of revenue for the both of them.

We are bullish on Kraig Biocraft Labortories. Sigma-Aldrich’s market cap is 8.16 billion and currently trades for $67,00 a share. They also employ over 7,900 employees. We feel the stock is under valued and the share price will begin to reflect this deal. The current share price is .105. Kraig Biocraft laboratories will be announcing some major updates shortly.

Aufklappen

----gesperrt wegen gutmenschentum, wünsche an der stelle allen alles gute, wie immer. http://investorshub.advfn.com/boards/profilea.aspx?user=193864

19.04.2012 20:26
Bild des Benutzers b00n
Offline
Kommentare: 5227

 

Crazy muhaha ich lach mich tot

 

ich werde nachdem wir forumuser so  gut betreut werden, natürlich SOFORT ein KONTO bei dem verein beantragen..

----gesperrt wegen gutmenschentum, wünsche an der stelle allen alles gute, wie immer. http://investorshub.advfn.com/boards/profilea.aspx?user=193864

07.04.2012 12:09
Bild des Benutzers b00n
Offline
Kommentare: 5227
transcrpit vom letzten CC is

transcrpit vom letzten CC is out

 

Our model is to partner with larger established companies in our target markets for product development, manufacturing and distribution. The first step has been to identify and begin discussions with appropriate potential partners. The pace of contact with potential partners has increased significantly, since the publication of the national academy of sciences article in January and also after the Textile World magazine article, also in the first quarter. Since those publications came out there has been a lot of interest in Monster Silk and we have been approached by a number of companies concerning the potential to use monster silk in their product lines, or to develop new products using monster silk

 

http://kraiglabs.com/Treanscript%20confrence%20call%203%2030%202012.htm

----gesperrt wegen gutmenschentum, wünsche an der stelle allen alles gute, wie immer. http://investorshub.advfn.com/boards/profilea.aspx?user=193864

31.03.2012 13:40
Bild des Benutzers b00n
Offline
Kommentare: 5227
paar links zum auscheken...

paar links zum auscheken...

 

http://www.entogenetics.com/history.html

 

Entogen schreibt über Kraig; schon etwas älter

http://entogenetics.wordpress.com/

 

zu guter letzt

 

http://www.charlotteobserver.com/2012/03/31/3138911/silk-with-spider-strength.html

 

nun bin ich etwas verwirrt. löl

----gesperrt wegen gutmenschentum, wünsche an der stelle allen alles gute, wie immer. http://investorshub.advfn.com/boards/profilea.aspx?user=193864

31.03.2012 13:16
Bild des Benutzers b00n
Offline
Kommentare: 5227
10Q kommt bald einmal,

10Q kommt bald einmal, jahresbericht.

Ich frag mich voerst mal wer denn die neuen Labs zahlen wird...

werde mal 10Q abwarten, glaube nicht das vorher signifikante news noch einschlagen werden.

Bis ich weis was geht, werd ich noch nicht eine neue pos. eröffnen.

aber ein Deal, wie im CC erwähnt kann theoretisch jeder zeit einschlagen.

 

----gesperrt wegen gutmenschentum, wünsche an der stelle allen alles gute, wie immer. http://investorshub.advfn.com/boards/profilea.aspx?user=193864

31.03.2012 13:09
Bild des Benutzers b00n
Offline
Kommentare: 5227
gestern war n CC, hier eine

gestern war n CC, hier eine zusammenfassung

KBLB signed a lease on a new lab - are moving into new facility. Will still be working with university labs but this will allow us to expand and increase our capabilities. This physical expansion is lock step with ramp up of monster silk production. 

National Academy of Sciences and Textile World articles have significantly increased the level of interest in our monster silk program during the first quarter. 

We have long since achieved homozygosity and the silkworms are definitely producing monster silk. 

Current monster silk fiber is stronger than what was described in Academy of Sciences’ article. 

Following Monster Silk development, Zinc Finger nucleus has been added to the KBLB arsenal. With it KBLB has created more than one knock out strain and they are currently working on a knock in strain. Anticipate one or more of these new knock outs will become the basis for a new platform technology. 

Gen 2 technology is in an advanced state of development. It is a primary RD focus but not exclusively during the second quarter. 

Gen 3 technology will be the focus of RD after the development of Gen 2. This platform will incorporate customizable fibers such as antibiotics. 

Our business model is to partner with established companies in our target market for product development, manufacturing, and distribution. First step has been to identify and begin discussions with potential partners. The pace of contact with potential partners has increased significantly with the two articles on Monster Silk. We have been approached by a number of companies for use of Monster Silk in their product lines or to develop new products using Monster Silk. 

During the first quarter we have entered into NDAs and CAs with a number of those companies ranging from sportswear and fashion to defense / military applications. These are large companies from billions to 50 millions of dollars in worth. We are in very early stages of discussions with each of these companies. We are also in contact with market development partners. These partners are aware KBLB is on track to develop more advanced spider silk products and know that by being involved with KBLB now they will have the inside track into future products. 

Kim does not see a spinoff in the immediately foreseeable future for KBLB as he feels at this time it would not be in the best interests of the shareholders. We are still a small company and we are stronger together than we would be broken apart. 

Every member of our advisory board brings a diverse expertise to the board. They are not involved on a day to day basis as they are also involved in other interests. That being said these folks are invaluable to Kim and he pays attention to them when he has questions relevant to their particular field of expertise. 

As to marketing Kim feels we have only one chance to select who we will be working with and we need to do this right. It's more important to do this right than it is to sign deals so we can say we signed deals. We are only looking for a few partners at this time. 

For example, one company may use our product for a particular sportswear application. Another company that weaves fabric for the defense industry might integrate our product into their product line. 

We are already talking to more marketing partners than we need. We will be selective based on long term plans. We want to make sure any prospective company we enter into a relationship with: 
1. Has the ability to move significant volume of products in the marketplace. 
2. Has necessary products and expertise to work with us on successfully integrating monster silk and eventually our Gen 2 products into their product line. 
3. They share our vision and passion for this breakthrough fiber. 

At the same time we are going to significantly increase our recombinant spider silk production through our Monster Silk brand. 

We are already underway in that ramp up process with a significant increase of silk worms and we are successfully stockpiling eggs in preparation for a significant increase of production capacity. 

New lab will increase that ramp up for industrial production. 

Sigma Aldridge will not be involved in distribution or production but we will continue utilizing their expertise with ZF. 

Defense contractors mentioned again with them contacting us with ideas for monster silk applications. This indicates the applicability of monster silk may be broader than we realized. 


Kim's Summary Statement: 
As company grows and we interact with larger companies in our target market, we need to grow internally as well as externally. We anticipate adding significant new corporate communications and investor relations support as part of our increasing public profile. 
Our lab is physically growing as we move part of our RD and production into the new lab. 
We are also accelerating our RD on the next Gen 2 technology. 
We are also ramping up production of our Monster Silk products. We are reaching out to form partnerships with existing companies in our target market. 

 

----gesperrt wegen gutmenschentum, wünsche an der stelle allen alles gute, wie immer. http://investorshub.advfn.com/boards/profilea.aspx?user=193864

10.02.2012 15:23
Bild des Benutzers WARSICS
Offline
Kommentare: 512
geniess dein frei und vor

geniess dein frei und vor allem den wein! verdient mein freund.


wb... ich war ja nie weg. hatte nur ein paar heisse deals drin mit AMD, ABB, BPAX - als ich die alle verscherbelt hatte brauchte ich eine sendepause.


in meinem forum würde ich dir und noch so manch einem aus dem "aktien ausland" sektion die einladung PERSÖNLICH vorbeibringen. gibt keinen eurer beiträge der für mich spam ist oder den ich nicht lese. ander im aktien schweiz teil. da motzt sich die hälfte an und palavert über gott und die welt nur nicht über den themen titel. wtf??


ich geniesse die elitäre runde hier sehr.

Handelnder Holländer

10.02.2012 12:37
Bild des Benutzers b00n
Offline
Kommentare: 5227
jup ich schon weis  geht mir

jup ich schon weis Smile  geht mir ja auch so

aber auf alle fälle, soszusagen wb welcome back !

ja TF, viele wurdn ja quasi per pn eingeladen da vorbeizuschauen, oder? ich zumindest nicht. was man daraus schliessen kann is klar oder.  Ich frag mich eh länger si meh ob ich überhaupt noch iwo posten soll. ich lass mich gern aus und teile gern vlt. is das für andere spam.

 

nja have a nice day, hab frei heut und hab mir einen tropfen gegönnt *grins*

----gesperrt wegen gutmenschentum, wünsche an der stelle allen alles gute, wie immer. http://investorshub.advfn.com/boards/profilea.aspx?user=193864

10.02.2012 12:28
Bild des Benutzers WARSICS
Offline
Kommentare: 512
 siehste... ich wollte nur

 


siehste... ich wollte nur ein doppelpunkt mit "o" und einer klammer zu posten... und nu macht das ding so eine entsetzte fratze dadraus...

Handelnder Holländer

10.02.2012 12:26
Bild des Benutzers WARSICS
Offline
Kommentare: 512
sali b00n. danke für den post

sali b00n. danke für den post und genaue ausführungen. KBLB finde ich immer spannend, hat mich nur verwundert dass "so wenig" läuft in letzter zeit. notre dame und sigma sind ja schon lange treue partner von unserem monsieur.


mit der übernahme ist zu rechnen. der typ revolutioniert und auch notre dame wird mit seiner ausstattung irgendwann nicht mehr reichen. 40 cents bis ende jahr wäre knüller.


mal schauen WANN ich wieder reingehe.


 


ja, ich hab mal im TF geschnuppert. ich gebe gerne zu, dass ich mit neuerungen die mir auf den 1. blick mehr komplexität im handling auflasten, nicht so happy bin. eigentlich ist das neue forum hier nicht schlechter als das alte (wegen der leute), aber ich will doch nur easy beiträge abtippen und ein paar daten, kurse, infos einfügen. zu viel geschnörkel hindert mich.


aber du siehst, ich bin wieder auf dem weg "rein" :o)


 


lg, schönes weekend

Handelnder Holländer

10.02.2012 10:45
Bild des Benutzers b00n
Offline
Kommentare: 5227
das war ja klar. wenn du dir

das war ja klar. wenn du dir das angehöhrt hast.

da wird am nächsten Gen gebastelt.

sowie Gen 1 geht in devlopment stage. d.h. LABORPRODUKTION erfolgreich.

ja onemanshow mit hauptaktionär UNI wyoming (Notre dame) und SIGMA ALDRICH..... nicht zu vergessen calm seas...

 

alles on track. sieht gerade nach support aus da um 0.08 herum. Habe persönlich auch wieder reduziert.. werde aber natürlich zu gegebener zeit massig aufstocken.

rechne mit ca. zwei ruhigen Monaten und einem target bis letztes q12 von 0.40.

alle Lizenzen , vertriebsrechte usw. gehören KBLB. der ONE MAN show

könnte mir sogar ein übernahmeangebot nach erfolgreichem G2 vorstellen... ganz zu schweigen beim G3.

Ich bin zuversichtlich und hab zeit.

Gruss an dich warsics, mal ausm trader forum rausgefunden..

----gesperrt wegen gutmenschentum, wünsche an der stelle allen alles gute, wie immer. http://investorshub.advfn.com/boards/profilea.aspx?user=193864

09.02.2012 11:59
Bild des Benutzers WARSICS
Offline
Kommentare: 512
 kurs bewegt sich kaum und

 


kurs bewegt sich kaum und volumen ist mässig. unüblich für die one.man.show. in der vergangenheit sind eben solche news das lebenselexier für KBLB gewesen...

Handelnder Holländer

07.02.2012 14:54
Bild des Benutzers b00n
Offline
Kommentare: 5227
 

 

    Quality Fabric Of The MonthSpider Silk: Potential UnleashedSpider silk technologies developed at the University of Notre Dame jointly with Kraig Biocraft Laboratories and the University of Wyoming are heading toward commercial availability.Janet Bealer Rodie, Managing EditorSpider silk has been the subject of advanced research and development efforts for years because it has exceptional strength, elasticity and abrasion resistance, as well as numerous potential technical textile applications — if only it could be produced in commercially viable quantities. That's been a problem because spiders are not exactly social creatures and, in fact, tend to be cannibalistic, so farming them as one would silkworms is not an option. However, a breakthrough has occurred thanks to collaboration involving the University of Notre Dame, Notre Dame, Ind.; Kraig Biocraft Laboratories Inc. (Kraig Labs), Lansing, Mich.; and the University of Wyoming, Laramie, Wyo.; and the first result — a hybrid silk produced by transgenic silkworms — is well on its way to commercialization primarily for traditional silk applications including apparel and medical applications such as sutures. 


Armed with an exclusive license to use patented technologies developed by Randolph Lewis at the University of Wyoming, Kraig Labs Founder and CEO Kim Thompson began working with Malcolm Fraser at Notre Dame, developer of piggyBac gene-splicing technology, and Donald Jarvis at the University of Wyoming. PiggyBac vectors have been used to combine certain spider silk proteins with silkworm proteins to create a transgenic silkworm that produces a composite silk that, while it comprises only about 5-percent spider silk protein, exhibits significantly increased strength and elasticity when compared to conventional silk. This hybrid silk is called Monster Silk, "a beautiful product," Thompson said, that has an entirely different hue and sheen than traditional silk. "The percentage of spider silk proteins in the fiber is not indicative of the fiber's strength," he said. "Those proteins are acting sort of like rebar in concrete, to create a reinforced fiber." 

Monster Silk can be produced in commercially viable volumes, and Kraig Labs, which has signed a commercialization agreement with Notre Dame, is exploring the possibility of acquiring an end-product manufacturer working in its target market. 

A Generation II 100-percent recombinant spider silk for technical textile applications is in advanced stages of development and soon is expected to be ready for commercialization. This fiber, developed using St. Louis-based Sigma-Aldrich Corp.'s zinc finger gene-splicing technology, would have advanced medical, composite and possibly ballistic applications, among others — spider silk is said to be stronger than aramid and 10 times as strong as steel. "I would like to see testing data before we make ballistic claims," Thompson said, "but there is discussion in the scientific literature that this material would be like a miracle product for ballistic resistance. I imagine it would be used in a composite product to reinforce, for example, ultra-high molecular weight polyethylene." 

A customizable Generation III fiber that can include various mechanical and chemical properties is also in development. 

 

http://www.textileworld.com/Articles/2012/January/Jan-Feb_issue/Departments/QFOM_Spider_Silk.html

 

----gesperrt wegen gutmenschentum, wünsche an der stelle allen alles gute, wie immer. http://investorshub.advfn.com/boards/profilea.aspx?user=193864

19.01.2012 14:57
Bild des Benutzers b00n
Offline
Kommentare: 5227
habs mir grad angehört

habs mir grad angehört

 

c00l.  

Drinks  

:bomb:

----gesperrt wegen gutmenschentum, wünsche an der stelle allen alles gute, wie immer. http://investorshub.advfn.com/boards/profilea.aspx?user=193864

19.01.2012 14:29
Bild des Benutzers b00n
Offline
Kommentare: 5227
 

 

Kraig Biocraft Laboratories Announces New CEO Interview

 

The audio interview is available at http://thestockradio.com/kim-thompson-kraig-biocraft-labs-pinkkblb/489. The interview covers topics including: accelerated research and development, commercialization, production, finance and other corporate news events.

 

----gesperrt wegen gutmenschentum, wünsche an der stelle allen alles gute, wie immer. http://investorshub.advfn.com/boards/profilea.aspx?user=193864

05.01.2012 18:49
Bild des Benutzers b00n
Offline
Kommentare: 5227
b00n hat am 05.01.2012 - 17

b00n hat am 05.01.2012 - 17:40 folgendes geschrieben:

FOX NEWS

 

Genetically Modified Silkworm Brings Spider-Man Web Closer to Reality

Read more: http://www.foxnews.com/scitech/2012/01/05/genetically-modified-silkworm-brings-spider-man-web-closer-to-reality/#ixzz1ibQB1zKE

 

 

hab heut 50k stk zugekauft..

 

noch wer drin?

----gesperrt wegen gutmenschentum, wünsche an der stelle allen alles gute, wie immer. http://investorshub.advfn.com/boards/profilea.aspx?user=193864

05.01.2012 18:29
Bild des Benutzers b00n
Offline
Kommentare: 5227
the independent legt nach

the independent legt nach

 

Well, it worked for Peter Parker: genetic scientists unleash power of the spider web  

Breakthrough may pave way for new biomaterials that could be used in medicine and engineering

 

http://www.independent.co.uk/news/science/well-it-worked-for-peter-parker-genetic-scientists-unleash-power-of-the-spider-web-6284220.html

 

----gesperrt wegen gutmenschentum, wünsche an der stelle allen alles gute, wie immer. http://investorshub.advfn.com/boards/profilea.aspx?user=193864

05.01.2012 17:40
Bild des Benutzers b00n
Offline
Kommentare: 5227
FOX NEWS

FOX NEWS

 

Genetically Modified Silkworm Brings Spider-Man Web Closer to Reality

Read more: http://www.foxnews.com/scitech/2012/01/05/genetically-modified-silkworm-brings-spider-man-web-closer-to-reality/#ixzz1ibQB1zKE

 

 

----gesperrt wegen gutmenschentum, wünsche an der stelle allen alles gute, wie immer. http://investorshub.advfn.com/boards/profilea.aspx?user=193864

05.01.2012 12:44
Bild des Benutzers b00n
Offline
Kommentare: 5227
 

 

Kraig Biocraft Laboratories Announces Peer Reviewed Publication of Spider Silk and Transgenic Silkworm Breakthroughs

 

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (PINKSHEETS: KBLB) is very happy to start the New Year by announcing that the Journal Proceedings of the National Academy of Sciences published a peer-reviewed scientific article describing the breakthrough creation of a spider silk fusion fiber, which was achieved by university scientists within the University of Wyoming and the University of Notre Dame, who are working cooperatively with Kraig Biocraft Laboratories.

......

"The fact that a publication as prestigious as Proceedings of the National Academy of Sciences has chosen to publish these results speaks for itself as to the significance of the scientific breakthrough," said Company founder and CEO, Kim K Thompson. "When I founded Kraig many people in both the business and scientific community said that what we were setting out to do was impossible. By maintaining a focused vision and by recruiting the very best minds in molecular biology, we have made the impossible a tangible reality."

......

 

 

"Congratulations to the scientific team as well as to the University of Notre Dame and the University of Wyoming. They deserve the accolades they are receiving with this publication," continued Thompson. "Our next steps are to commercialize these developments while accelerating our development of even more advanced products. The commercial license agreement we signed in the fourth quarter of 2011 was an essential element of the former. As we move toward commercialization of these fibers, we are simultaneously moving into an advanced stage in the development of new, second generation spider silk polymers."

......

http://ih.advfn.com/p.php?pid=nmona&article=50627101

----gesperrt wegen gutmenschentum, wünsche an der stelle allen alles gute, wie immer. http://investorshub.advfn.com/boards/profilea.aspx?user=193864

03.01.2012 12:21
Bild des Benutzers b00n
Offline
Kommentare: 5227
News around the world...

News around the world...

 

http://uk.onlinenigeria.com/news/breaking-news/5533-scientists-genetically-engineer-spider-silk-using-silkworms.html 

http://www.telegraph.co.uk/science/science-news/8988901/Scientists-make-silkworms-spin-spider-webs.html 

http://www.independent.co.uk/news/science/well-it-worked-for-peter-parker-genetic-scientists-unleash-power-of-the-spider-web-6284220.html 

http://www.newsbullet.in/world/52-more/23877-spider-twist-leads-to-hybrid-silk-yarn 

http://manchesteronlinenews.co.uk/2012/scientists-genetically-engineer-spider-silk-using-silkworms/ 

http://www.anhourago.eu/show.aspx?l=49222303&d=504 

http://in.news.yahoo.com/spider-twist-leads-hybrid-silk-yarn-231415513.html 

 

oben ist da jeweils von der UNI wyoming die rede nachfolgend der zusammenhang;

 

"The commercial license agreement which the Company signed last month with the University covers these technologies and gives Kraig Biocraft Laboratories the exclusive global right to market the products and technologies described in the patent application," continued Thompson. "We see this filing in Geneva, coupled with our license agreements with the University of Wyoming, the University of Notre Dame and our license agreement with Sigma-Aldrich, as the corner stones of our expanding intellectual property portfolio. We feel well armed as we move forward to bring recombinant spider-silk to market." 


http://www.marketwire.com/press-release/kraig-biocraft-laboratories-announces-filing-international-patent-application-spider-pinksheets-kblb-1596145.htm 

apropos, aktuell günstig bewertet aus meiner sicht

----gesperrt wegen gutmenschentum, wünsche an der stelle allen alles gute, wie immer. http://investorshub.advfn.com/boards/profilea.aspx?user=193864

14.11.2011 22:12
Bild des Benutzers b00n
Offline
Kommentare: 5227
newsalert

Date : 11/14/2011 @ 4:05PM

Kraig Biocraft Laboratories Announces Creation of Seven New Strains of Transgenic Silkworms Using Zinc Finger Nuclease Techno...

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (PINKSHEETS: KBLB) (the "Company" or "Kraig") announced that researchers at the University of Notre Dame, utilizing customized zinc finger configurations licensed to Kraig from Sigma-Aldrich, succeeded in creating seven or more strains of transgenically modified silkworms.

The Company believes that this breakthrough removes the largest barrier to pure spider silk technology.

The zinc finger nuclease were designed to cleave the silkworm's native heavy chain gene. The resulting silkworms were inter-mated to produce 50 mating pairs, which each produced clutches of approximately 100 eggs. Genetic testing designed to detect mutations at the site of zinc finger cleavage were preformed and the testing recovered positive results for zinc finger disruption, therefore knockout of the native heavy chain gene in embryos, from 7 of the first 13 mating pairs, analyzed.

"This success rate is much higher than we ever expected," said Company CEO and founder Kim Thompson. "The laboratory reports that seven new strains of transgenics have been confirmed so far."

"The bottom line is that zinc finger nuclease works exceedingly well for our particular targets. Our adopting this technology was a bit of a gamble at the time, but it turns out to have been one of the smartest moves we could have made. We view this genetic knockout as the achievement of our greatest scientific goal for 2011," continued Thompson.

Dr. Malcolm Fraser reported, "We anticipate that we will be able to recover homozygous knockout silkworms from these pools of embryos with little difficulty. These homozygous commercial strain heavy chain knockouts will serve as a more effective platform technology for rapid development and commercialization of future spider silk transgenics, allowing us to readily recover commercially ready spider silk transgenics by simply screening for the production of cocoons."

Dr. Fraser concluded, "This Zinc Finger approach exceeded our best expectations in terms of its capabilities for introducing mutations in silkworms. The frequency of mutation events and the capability of working directly with the commercial strains give a much more rapid route to new, commercially relevant transgenics."

The Company believes that the next generation of its technology, which utilizes zinc fingers, will significantly expand its product capabilities and target markets.

Thompson further stated, "Dr. Fraser and his team have once again verified our scientific models. The results also serve as proof of efficacy for the creation of targeted transgenics, and confirm our confidence in the power of zinc finger technologies. We now believe that we have both the platform and targeted transgenic capabilities which we need to create Generation II and Generation III technical textiles."

The Company is already ramping up production of Monster Silk, its previously disclosed product which is the subject of the Company's recent licensing agreement with the University of Notre Dame. While Monster Silk is targeted for conventional applications, the Company believes that the technology described in today's announcement will ultimately unlock applications for technical textiles and broader markets. :!:

----gesperrt wegen gutmenschentum, wünsche an der stelle allen alles gute, wie immer. http://investorshub.advfn.com/boards/profilea.aspx?user=193864

03.11.2011 14:02
Bild des Benutzers b00n
Offline
Kommentare: 5227
news

Kraig Biocraft Laboratories, Inc. Signs Spider Silk Commercial License Agreement With the University of Notre Dame

Kraig Biocraft Labs (QB) (USOTC:KBLB)

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (PINKSHEETS: KBLB) (the "Company" or "Kraig") announced that it signed a commercial license agreement with the University of Notre Dame regarding spider silk technologies.

The agreement awards Kraig the exclusive worldwide commercial rights to certain spider silk technologies which the Company jointly developed with the University of Notre Dame. Pursuant to the agreement, the University of Notre Dame will become a shareholder of the Company. The University will also receive a 2% royalty of the Company's net sales of products which incorporate the technology.

The subject of the agreement is the definitive spelling out of rights for the commercialization of what the Company refers to as "generation one" spider silk technology. The agreement confirms the Company's exclusive right to the commercial development of spider silk textiles derived from the subject technology.

"Due to the significance of this technology it was important that we craft an agreement that benefits Kraig, our shareholders and the University," stated Kim Thompson, Company CEO and founder. "We are very happy to welcome the University of Notre Dame as our newest shareholder. We are also very happy to formally consummate this commercial license agreement covering the commercial rights to this exciting technology which we have been developing with the University."

"Our collaboration with university laboratories has been fundamental to the rapid progress we have made in the development of spider silk," Thompson continued. "The commercial license agreement reflects that sentiment and lays the groundwork for the Company's commercialization of spider silk technologies."

----gesperrt wegen gutmenschentum, wünsche an der stelle allen alles gute, wie immer. http://investorshub.advfn.com/boards/profilea.aspx?user=193864

29.10.2011 14:33
Bild des Benutzers b00n
Offline
Kommentare: 5227
Kraig Biocraft Laboratories Inc (Public, PINK:KBLB)

hier was von nem SIGMA Aldrich typen....

read it

http://www.labnews.co.uk/features/silk-spinning-the-genetically-modified...

die sache scheint auf gutem weg zu sein

-----

News von KB erwartet, gem. letzter PRS, im Herbst.

gestern ansehlicher kaufdruck.

----gesperrt wegen gutmenschentum, wünsche an der stelle allen alles gute, wie immer. http://investorshub.advfn.com/boards/profilea.aspx?user=193864

28.09.2011 15:52
Bild des Benutzers WARSICS
Offline
Kommentare: 512
KBLB

hier sieht es wieder passabel und freundlich aus nach den neulichen tauchern. bin treu geblieben und halte wieder kurs gen gewinnzone.

watch it!

Handelnder Holländer

17.08.2011 18:14
Bild des Benutzers b00n
Offline
Kommentare: 5227
Kraig Biocraft Laboratories Inc (Public, PINK:KBLB)

zurück auf ma 200 hoffe auf knacken ma20.. dann dürften hurti einige prozente drin liegen.

----gesperrt wegen gutmenschentum, wünsche an der stelle allen alles gute, wie immer. http://investorshub.advfn.com/boards/profilea.aspx?user=193864

08.08.2011 15:19
Bild des Benutzers WARSICS
Offline
Kommentare: 512
Kraig Biocraft Laboratories Inc (Public, PINK:KBLB)

noch keine ergebnisse von der 1st round aber schon 2nd round am durchjagen. wird den kurs in dem heutigen umfeld nicht so sehr beflügeln wie gewünscht aber zumindest im akzeptablem bereich halten während der rest den bach runter geht

http://www.marketwatch.com/story/kraig-biocraft-laboratories-completes-scheduled-second-round-of-micro-insertions-using-zinc-finger-technology-2011-08-08?reflink=MW_news_stmp

Handelnder Holländer

03.08.2011 18:05
Bild des Benutzers b00n
Offline
Kommentare: 5227
Re: erste früchtchen mit Sigma s ZF technologie

b00n wrote:

jup wunderbar..scheint gut zu kommen.

Kraig Biocraft Laboratories Announces the Completion of Its First Zinc Finger Micro-Insertions

Kraig Biocraft Labs (QB) (USOTC:KBLB)

Intraday Stock Chart

Today : Tuesday 5 July 2011

Click Here for more Kraig Biocraft Labs (QB) Charts.

Kraig Biocraft Laboratories, Inc. (PINKSHEETS: KBLB) announced the completion of its first round of zinc finger micro-insertions.

"We are very excited to be performing these genetic engineering feats so soon after signing the agreement for their use with Sigma-Aldrich," said CEO and company founder, Kim K. Thompson. "The immediate results from this first round of generic insertion are truly encouraging, as we observed a high hatch rate within a few days of employing the new technology."

In April, Kraig entered into an agreement with Sigma-Aldrich to use Sigma's powerful zinc finger technology to accelerate Kraig's scientific research and product development. The zinc fingers are an effective genetic engineering technology that the Company is using to create the next generation of biomaterials, including recombinant spider silks, for the textile and technical textile markets.

"The company has very high expectations for these newly hatched silkworms and we are watching their development closely," Thompson continued. "As of yet, the caterpillars are far too small for us to determine whether we hit our genetic target. So far, the technology is performing as anticipated and, even as we monitor the development of these silkworms, we are preparing for the next round of micro-insertions."

ja eben, diese ZF technologie...

hier kam grad was von sigma zu dem thema..

Sigma® Life Science Reaches Milestone in Gene Editing with Increased Affordability for CompoZr® ZFNs and the Expansion of Knockout ZFNs to Include Every Gene in Mice and Rats

Advances in technology platform and new production center result in more content and less expensive CompoZr ZFNs

ST. LOUIS, Aug. 3, 2011 /PRNewswire/ -- Sigma Life Science, the innovative biological products and services research business of Sigma-Aldrich® (Nasdaq:SIAL), today announced a major breakthrough in the development of its proprietary CompoZr zinc finger nuclease (ZFN) technology with the release of more Knockout ZFNs covering the entire genomes of both mice and rats, while the pricing of products within the CompoZr ZFN portfolio by half. A new dedicated high-throughput manufacturing center, together with advances in ZFN design algorithms and production processes, has led to cost reductions in the development and production for both CompoZr Custom and Knockout ZFNs. This has allowed Sigma Life Science to extend the range of its Knockout ZFNs and to make ZFN technology more affordable to the scientific community. For more information visit www.sigma.com/zfn.

The increased capacity of the new manufacturing facility allows Sigma Life Science to rapidly develop its CompoZr Knockout ZFN portfolio, bringing the advantages of this technology to many previously underserved research fields. The expansion of the Knockout ZFNs for every mouse and rat gene is in its initial phase, which complements the existing range of Knockout ZFNs for the entire human genome. This exciting milestone in genome editing can enable the scientific community to pursue previously unachievable research quickly and easily with validated tools, avoiding the cost, time and uncertainty associated with other techniques.

ZFN technology has been widely recognized as the most efficient and versatile method of genetic engineering for cell lines and whole organisms, offering precisely targeted, permanent and heritable modifications in a fraction of the time required using more traditional technologies. ZFNs have been broadly adopted within the biotechnology and pharmaceutical sectors, but the high cost of designing and manufacturing CompoZr ZFNs has at times limited the research community's access to this technology. To address this issue, Sigma Life Science invested heavily in advancing both its design and production processes to drive down costs and in an effort to help researchers accelerate scientific discovery. The new development and manufacturing facility is expected to ensure affordable pricing for Sigma's complete range of CompoZr ZFN offerings and further extend the scope of this powerful genome editing technology.

David Smoller, Chief Scientific Officer at Sigma Life Science, commented, "Sigma Life Science has reached another milestone in our quest to provide the research community with greater access to ZFN technology. CompoZr ZFNs are now available in multiple formats, multiple species and at more accessible pricing. It is now our objective to continue to drive the development of new applications for CompoZr ZFNs, while maintaining this vital affordability."

Cautionary statement: The foregoing release contains forward-looking statements that can be identified by terminology such as "can enable," "expected," "our objective," or similar expressions, or by expressed or implied discussions regarding potential future revenues from products derived there from. You should not place undue reliance on these statements. Such forward-looking statements reflect the current views of management regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that CompoZr ZFN Technology will assist the Company to achieve any particular levels of revenue in the future. In particular, management's expectations regarding products associated with that CompoZr ZFN Technology could be affected by, among other things, unexpected regulatory actions or delays or government regulation generally; the Company's ability to obtain or maintain patent or other proprietary intellectual property protection; competition in general; government, industry and general public pricing pressures; the impact that the foregoing factors could have on the values attributed to the Company's assets and liabilities as recorded in its consolidated balance sheet, and other risks and factors referred to in Sigma-Aldrich's current Form 10-K on file with the US Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. Sigma-Aldrich is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.

----gesperrt wegen gutmenschentum, wünsche an der stelle allen alles gute, wie immer. http://investorshub.advfn.com/boards/profilea.aspx?user=193864

18.07.2011 23:01
Bild des Benutzers WARSICS
Offline
Kommentare: 512
Kraig Biocraft Laboratories Inc (Public, PINK:KBLB)

nice one. einzig dieser titel rettet ein tief rotes portfolio heute.

habe mir übrigens noch threshold pharma gezogen. sauberer pick.

Handelnder Holländer

18.07.2011 17:40
Bild des Benutzers b00n
Offline
Kommentare: 5227
Kraig Biocraft Laboratories Inc (Public, PINK:KBLB)

mal andere Töne von hotstocked...

nich das übliche one man company gepimpe..

http://www.hotstocked.com/article/14461/.html

----gesperrt wegen gutmenschentum, wünsche an der stelle allen alles gute, wie immer. http://investorshub.advfn.com/boards/profilea.aspx?user=193864

05.07.2011 23:12
Bild des Benutzers b00n
Offline
Kommentare: 5227
erste früchtchen mit Sigma s ZF technologie

jup wunderbar..scheint gut zu kommen.

Kraig Biocraft Laboratories Announces the Completion of Its First Zinc Finger Micro-Insertions

Kraig Biocraft Labs (QB) (USOTC:KBLB)

Intraday Stock Chart

Today : Tuesday 5 July 2011

Click Here for more Kraig Biocraft Labs (QB) Charts.

Kraig Biocraft Laboratories, Inc. (PINKSHEETS: KBLB) announced the completion of its first round of zinc finger micro-insertions.

"We are very excited to be performing these genetic engineering feats so soon after signing the agreement for their use with Sigma-Aldrich," said CEO and company founder, Kim K. Thompson. "The immediate results from this first round of generic insertion are truly encouraging, as we observed a high hatch rate within a few days of employing the new technology."

In April, Kraig entered into an agreement with Sigma-Aldrich to use Sigma's powerful zinc finger technology to accelerate Kraig's scientific research and product development. The zinc fingers are an effective genetic engineering technology that the Company is using to create the next generation of biomaterials, including recombinant spider silks, for the textile and technical textile markets.

"The company has very high expectations for these newly hatched silkworms and we are watching their development closely," Thompson continued. "As of yet, the caterpillars are far too small for us to determine whether we hit our genetic target. So far, the technology is performing as anticipated and, even as we monitor the development of these silkworms, we are preparing for the next round of micro-insertions."

----gesperrt wegen gutmenschentum, wünsche an der stelle allen alles gute, wie immer. http://investorshub.advfn.com/boards/profilea.aspx?user=193864

05.07.2011 15:27
Bild des Benutzers WARSICS
Offline
Kommentare: 512
Kraig Biocraft Laboratories Inc (Public, PINK:KBLB)

link erst ma nich anklicken, glaube ich habe mir da einen virus gezogen... gopf

Handelnder Holländer

Seiten